phaceMedical

phaceMedical is a Greek pharmaceutical startup founded in 2014 with a mission to introduce innovative medical aesthetics brands and products into the Greek professional skincare market. The company aims to assist skincare professionals in effectively addressing various skin concerns such as aging, hyperpigmentation, acne, local fat, cellulite, hair loss, and rosacea.

With its focus on the medical aesthetics segment, phaceMedical presents an attractive opportunity for potential investors seeking to tap into the growing demand for advanced skincare solutions. The company's commitment to bringing innovative products to the Greek market positions it as a potential disruptor in the skincare industry.

As of now, phaceMedical hasn't disclosed its last investment or the involved investors, which could indicate an opportunity for venture capital firms to consider the potential for strategic partnerships or investment in the company. Given its niche focus and the potential for growth in the skincare industry, phaceMedical presents an intriguing investment prospect for venture capitalists seeking exposure to the pharmaceutical sector.

Overall, phaceMedical's dedication to introducing cutting-edge medical aesthetics brands and products to the Greek market, coupled with the potential for future investment and partnerships, positions the company as an exciting player in the evolving landscape of professional skincare in Greece.